Hematology/Oncology

Top Story

Adoption of stereotactic body radiation therapy improves OS in elderly patients with NSCLC

Adoption of stereotactic body radiation therapy improves OS in elderly patients with NSCLC
September 27, 2016

The widespread adoption of stereotactic body radiation therapy to treat elderly patients with early-stage non–small cell lung cancer has improved survival rates, according to retrospective, population-based study results presented at the ASTRO Annual Meeting.

Stereotactic body radiation therapy — which delivers highly targeted, escalated radiation in one to five sessions — has become the standard of care for patients with inoperable early-stage NSCLC. In particular, its adoption has increased in elderly patients, who often have comorbidities that limit surgical options.

BRAF/MEK inhibitor combination extends PFS in melanoma

September 27, 2016
A phase 3 study designed to evaluate combined BRAF and MEK inhibition in patients with BRAF–mutant advanced, unresectable or metastatic melanoma met its primary…
Meeting News Coverage

Postoperative stereotactic radiosurgery improves local control of brain metastases

September 27, 2016
Stereotactic radiosurgery provided better local control than observation in patients with resected brain metastases, according to randomized study results presented at…
In the Journals

Black men who smoke, drink have high risk for esophageal squamous cell carcinoma

September 27, 2016
Black men who have ever smoked tobacco and drank alcohol have the highest incidence of esophageal squamous cell carcinoma compared with other races and women, according…
Meeting News Coverage

Telephone helpline increases access to cancer prevention, control programs

September 27, 2016
The addition of a telephone-based cancer control navigation intervention to a helpline’s existing services helped callers access cancer control measures, according…
More News Headlines »
CME Video

NSCLC Treatment on Target: Examining New Evidence and Advances

This activity is supported by an educational grant from Genentech, Inc. and Merck & Co., Inc.

Globally, lung cancer is the leading cause of cancer-related deaths. Eighty five percent of lung cancers are non-small…
More »
Video
Meeting News Coverage

VIDEO: Crenolanib, venetoclax demonstrate ‘very exciting’ results in AML

August 21, 2016
More »
Featured
At Issue: Breast Cancer Resource Center

At Issue: Breast Cancer Resource Center

CME

Updates from Vienna 2015 – Highlights in Hematologic Malignancies

This activity is supported by an educational grant from Genentech, Inc.

The management of patients with hematologic malignancies—from diagnosis to treatment decisions—can represent a…
More »
Current Issues
View the Current Issue
HemOnc Today
morganatic-roan